Yesterday's news that the FDA hearing went south and Avastin was not going to be approved for use for advanced stage breast cancer struck fear in the hearts of all the women who are currently benefiting from the drug.
What did this mean? Where will they turn? Would insurance companies still cover it on a compassionate basis?
A major step forward happened today: Medicare announced it would continue covering it. You can read about it here.
Insurance companies: Follow their lead. DO NOT STOP COVERING AVASTIN FOR WOMEN WITH BREAST CANCER.